Details for New Drug Application (NDA): 210675
✉ Email this page to a colleague
The generic ingredient in DOXEPIN HYDROCHLORIDE is doxepin hydrochloride. There are seven drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the doxepin hydrochloride profile page.
Summary for 210675
Tradename: | DOXEPIN HYDROCHLORIDE |
Applicant: | Epic Pharma Llc |
Ingredient: | doxepin hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 210675
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 210675 | ANDA | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 24658-793 | 24658-793-01 | 100 CAPSULE in 1 BOTTLE (24658-793-01) |
DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 210675 | ANDA | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 24658-793 | 24658-793-10 | 1000 CAPSULE in 1 BOTTLE (24658-793-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Oct 16, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Oct 16, 2020 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Oct 16, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription